Press
A Valladolid -based company develops a test for the diagnosis of Alzheimer’s disease in blood samples.
The company recently completed a multicenter exploratory study in which seven Spanish hospitals participated, to identify markers of the disease. The study involved 306 patients.
Biocross becomes the main sponsor of Positive SimRacing
Biocross is a young Spanish biotechnology company based in the bioincubator in Boecillo Technology Park, near the headquarters of Positive SimRacing in Valladolid (Spain).
Alzheimer’s in the spotlight
Biocross is a biotechnology company that was created in the National Center for Biotechnology in Madrid, and recently moved to the bioincubator in Boecillo Technology Park (Valladolid).
Biocross: a multiparametric method for the blood-based diagnosis of Alzheimer’s disease
Early diagnosis a key tool in the fight against disease. It is thus essential that currently available tools are continually improved. Biocross has defined 3 main objectives that will guide the direction of this project.
Approval of a clinical study for the identification in blood of markers.
Biocross announces approval of a clinical study for the identification in blood of markers for the diagnosis of Alzheimer’s disease using a multiparametric test – September 2011.
The Junta’s venture capital fund regains momentum with investment in biotechnology.
After nearly six months of inactivity, venture capital firm Ade Sodical, owned by the Junta de Castilla y Leon, has been reactivated with an investment in Biocross.
Avda. Francisco Vallés, 8
47151 Boecillo (Valladolid) - Spain
+34 983 54 98 96
